Hoth Therapeutics, Inc. , a patient-focused biopharmaceutical company advancing breakthrough therapies for diseases, today announced that the United States Patent and Trademark Office (USPTO) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results